The report offers new insights into the limits of the BCL2 inhibitor among patients who have myelodysplastic syndromes. A new report explains why patients with myelodysplastic syndromes (MDS) become ...

Researchers at Moffitt Cancer Center and colleagues at six other institutions have recently tested a treatment for patients with myelodysplastic syndrome, or MDS, a blood-related malignancy that ...

We expect the cramps, bloating, mood swings, breast tenderness and breakouts associated with our monthly period. But for many women, especially during perimenopause, period diarrhea is also a problem.

Distinguishing myelodysplastic syndrome (MDS) from acute myeloid leukemia (AML) solely on the basis of a 20% bone marrow blast cutoff ignores important patient characteristics and genetic factors that ...

Patients with histories of inflammatory bowel disease and systemic lupus erythematosus were also at elevated risks of myelodysplastic syndromes (MDS), the authors found. A new report shows that ...

An expert explained the burden that red blood cell transfusions can place on patients with MDS. Among patients with myelodysplastic syndromes (MDS), treatment with Reblozyl (luspatercept) resulted in ...

Myelodysplastic syndromes (MDS) are a group of blood cancers that affect the bone marrow and can result in a low levels of blood cells. When MDS affects red blood cells, it can lead to anemia in some ...

Myelodysplastic syndromes (MDS) are blood cancers caused by an insufficient production of healthy blood cells. Production of irregular cells leads to anemia, where the body’s organs and tissues don’t ...

Fatigue is a common symptom in myelodysplastic syndromes (MDS), even during treatment. While you may not be able to completely eliminate feelings of exhaustion, lifestyle strategies can help you ...